By David Zalubowski | The Associated Press | August 10, 2021
Buoyed by a major, unanimous U.S. Supreme Court ruling, some states are pressing ahead with efforts to rein in one of the most obscure—but also most potent—players in the prescription drug supply chain. [read full article]